27 July 2000. Joseph F. Poduslo and colleagues at Mayo Clinic report in the August
issue of Nature Biotechnology (pp. 868-872) on a technique for imaging Aβ
deposits in living brain. The approach may allow an earlier diagnosis of Alzheimer's
disease, thus opening the door to early therapeutic interventions. Using a transgenic
mouse model that develops Aβ deposits, the Mayo scientists showed that neuritic-type
plaques can be radioactively labeled. They injected synthetic Aβ labeled with
a radioactive isotope of iodine (125I), which crossed the blood-brain barrier
and bound to neuritic plaques. Although the results are encouraging, the researchers
need to improve plaque labeling efficiency to achieve more widespread plaque labeling,
perhaps through experiments with other probes or different types and modification
of Aβ protein, and use of 123I, an isotope that is more suitable for diagnostic
imaging.-Hakon Heimer.